MacroGenics Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
MacroGenics, Inc. income statement - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenue & Gross Profit
Revenue149.9658.75151.9477.4597.7664.1960.12
Cost of Revenue189.49174.81214.41217.23193.200.000.00
Gross Profit-39.53-116.06-62.47-139.7897.7664.190.00
Operating Expenses
Research & Development177.19166.58207.03214.58193.20195.31190.83
Selling, General & Administrative71.0552.1958.9563.0142.7446.0640.50
Operating Expenses71.0552.1958.9563.01235.94241.37231.33
Operating Income-110.58-168.24-121.42-202.80-131.06-177.19-171.21
Other Income/Expense
Interest Income9.429.691.660.680.800.000.00
Interest Expense-1.12-1.430.000.000.000.000.00
Other Income/Expense44.56150.931.66-0.68-1.32-25.37-0.25
Income
Income Before Tax-66.02-9.06-119.76-202.12-129.74-151.81-171.45
Income Tax Expense0.94-0.16-7.39-12.81-8.10-9.520.00
Net Income-66.97-9.06-119.76-202.12-129.74-151.81-171.45
Net Income - Continuous Operations-66.97-9.06-119.76-202.120.000.000.00
Net Income - Discontinued Operations0.000.000.000.000.000.000.00
EBITDA-103.04-158.60-109.55-191.54-119.10-140.97-162.05
EBIT-110.58-168.24-121.42-202.80-131.06-151.81-171.21
Depreciation & Amortization7.549.6511.8711.2612.0012.300.00
Earnings Per Share
Basic EPS-1.00--2.00-3.00-2.00-3.00-4.00
Diluted EPS-1.00--2.00-3.00-2.00-3.00-4.00
Basic Shares Outstanding62.6261.9361.4359.9452.4448.0840.93
Diluted Shares Outstanding62.6261.9361.4359.9452.4448.0840.93